quinidine has been researched along with sdz psc 833 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Kakee, A; Kusuhara, H; Lemaire, M; Sugiyama, Y; Suzuki, H; Terasaki, T | 1 |
| Fromm, MF; Kim, RB; Leake, B; Roden, DM; Wandel, C; Wilkinson, GR; Wood, AJ | 1 |
| Cvetkovic, M; Fromm, MF; Kim, RB; Leake, B; Wilkinson, GR | 1 |
| Choo, EF; Imamura, H; Kim, RB; Leake, B; Wandel, C; Wilkinson, GR; Wood, AJ | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Boesch, D; Loor, F; Muller, K; Pourtier-Manzanedo, A | 1 |
| Fendrich, Z; Kopecky, M; Libra, A; Nobilis, M; Novotna, M; Pavek, P; Semecky, V; Sklenarova, H; Staud, F | 1 |
| Cisternino, S; Debray, M; Rousselle, C; Scherrmann, JM | 1 |
| Dirson, G; Farinotti, R; Fernandez, C; German-Fattal, M; Gimenez, F; Hindlet, P; Roux, F | 1 |
| Abonyi, T; Beéry, E; Erdo, F; Fazakas, C; Herédi-Szabó, K; Kis, E; Krajcsi, P; Krizbai, I; Makai, I; Molnár, PM; Sziráki, I; Tóth, GK; Wilhelm, I | 1 |
| Erdő, F; Fazakas, C; Kis, E; Krajcsi, P; Krizbai, I; Molnár, J; Molnár, PM; Rajnai, Z; Sike, M; Sziráki, I; Trampus, P; Wilhelm, I | 1 |
| de Graaf, IA; de Jager, MH; Groothuis, GM; Li, M | 1 |
| de Graaf, IA; de Jager, MH; Groothuis, GM; Li, M; Siissalo, S; van Dam, A | 1 |
| de Graaf, IA; de Jager, MH; Groothuis, GM; Li, M; van de Steeg, E | 1 |
| Bajza, Á; Bors, LA; Cserey, G; Erdő, F; Imre, T; Mándoki, M; Szabó, P; Tasi, BJ | 1 |
18 other study(ies) available for quinidine and sdz psc 833
| Article | Year |
|---|---|
P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Cyclosporins; Male; Mice; Mice, Knockout; Quinidine; Rats; Rats, Wistar | 1997 |
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Intestinal Absorption; Male; Mice; Nelfinavir; Saquinavir | 1998 |
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Caco-2 Cells; Carrier Proteins; Genes, MDR; HeLa Cells; Histamine H1 Antagonists; Humans; LLC-PK1 Cells; Mice; Rats; Swine; Terfenadine; Tissue Distribution; Transfection; Vaccinia virus | 1999 |
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Caco-2 Cells; Dibenzocycloheptenes; HIV Protease Inhibitors; Humans; Inhibitory Concentration 50; Male; Mice; Quinolines; Testis | 2000 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
Topics: Amiodarone; Animals; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Flow Cytometry; Leukemia, Experimental; Leukemia, Myeloid; Microscopy, Fluorescence; Quinacrine; Quinidine; Tumor Cells, Cultured; Verapamil | 1991 |
Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Chlorpromazine; Cyclosporins; Drug Interactions; Female; Fluorescent Dyes; Placenta; Pregnancy; Quinidine; Rats; Rats, Wistar; Rhodamine 123; Sodium Azide | 2003 |
In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Colchicine; Cyclosporins; Dexamethasone; Drug Interactions; Male; Mice; Mice, Inbred Strains; Morphine; Progesterone; Quinidine; Verapamil; Vinblastine | 2004 |
Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
Topics: Alkynes; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzoxazines; Blood-Brain Barrier; Brain; Cell Line; Cyclopropanes; Cyclosporins; Digoxin; Endothelial Cells; Male; Mice; Mice, Knockout; Oxazines; Piperidines; Quinidine; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Triazines | 2006 |
Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Products; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Coculture Techniques; Cyclosporins; Digoxin; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Drug Interactions; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; High-Throughput Screening Assays; Immunosuppressive Agents; Male; Microdialysis; Quinidine; Rats; Rats, Wistar | 2011 |
The use of microdialysis techniques in mice to study P-gp function at the blood-brain barrier.
Topics: Anesthesia; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cells, Cultured; Cyclosporins; Drug Interactions; Endothelial Cells; Feasibility Studies; Humans; Male; Mice; Microdialysis; Quinidine; Rats; Substrate Specificity; Time Factors | 2013 |
Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; In Vitro Techniques; Intestinal Mucosa; Isoquinolines; Ketoconazole; Male; Quinazolines; Quinidine; Rats, Wistar; Rhodamine 123; Verapamil | 2015 |
The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Cytochrome P-450 CYP3A; Drug Interactions; Ileum; Intestinal Absorption; Jejunum; Ketoconazole; Male; Pharmaceutical Preparations; Quinidine; Rats; Rats, Wistar; Valine; Verapamil | 2016 |
The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colon; Cyclosporins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ileum; In Vitro Techniques; Isoquinolines; Jejunum; Ketoconazole; Male; Middle Aged; Quinazolines; Quinidine; Verapamil | 2017 |
Modulation of nose-to-brain delivery of a P-glycoprotein (MDR1) substrate model drug (quinidine) in rats.
Topics: Administration, Intranasal; Adrenergic alpha-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Cyclosporins; Drug Compounding; Drug Delivery Systems; Drug Interactions; Drug Resistance, Multiple; Male; Models, Anatomic; Printing, Three-Dimensional; Quinidine; Rats; Rats, Wistar | 2020 |